A team led by Michel Sadelain, MD, PhD, Director of the Center for Cell Engineering at Memorial Sloan-Kettering Cancer Center, has shown for the first time the effectiveness of a new technique that could allow the development ...
Dec 16, 2012
0
0
Cedars-Sinai Heart Institute researchers have reprogrammed ordinary heart cells to become exact replicas of highly specialized pacemaker cells by injecting a single gene (Tbx18)–a major step forward in the decade-long search ...
Dec 16, 2012
1
0
(Medical Xpress)—Findings from a new University of Reading study could lead to cheaper, wider and more effective stem cell research and treatment of disease.
Dec 12, 2012
0
1
VIB researchers from UGent and Vrije Universiteit Brussel , together with a team of the firm Oxyrane have developed a new technology that can lead to a more efficient and possibly also cheaper therapy for diseases such as ...
Nov 19, 2012
0
0
(HealthDay)—For patients with hereditary angioedema (HAE), weekly administration of recombinant C1INH (rhC1INH) is well tolerated and is associated with a reduction in attack frequency, according to a study published online ...
Nov 9, 2012
0
0
(Medical Xpress)—While the United States has largely been spared the scourge of mosquito-borne diseases endemic to the developing world—including yellow fever, malaria and dengue fever—mosquito-related illnesses in ...
Oct 24, 2012
0
0
Melbourne researchers have developed cows' milk that protects human cells from HIV.
Oct 17, 2012
0
0
The Molecular and Industrial Biotechnology Group of the Universitat Politècnica de Catalunya · BarcelonaTech (UPC) has improved the antimicrobial properties of medical textiles using an enzymatic pre-treatment combined ...
Oct 16, 2012
0
0
For the first time, scientists have visualised an interaction between gluten and T-cells of the immune system, providing insight into how coeliac disease, which affects approximately 1 in 133 people, is triggered.
Oct 11, 2012
0
0
Using biological markers—genetic characteristics that are associated with some patients with breast cancer—can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research ...
Oct 1, 2012
0
0
